Schedule 13G ownership disclosure
CytomX Therapeutics Inc
Security class unavailable · CUSIP: 23284F105
Event date: 2024-05-02
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 7.3800%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000929638-24-001775
- Form type
- SC 13G
- Filer
- Cormorant Asset Management, LP
- CIK
- CIK 1583977
- Filed
- May 13, 2024
- Reporting period
- May 02, 2024
- Description
- Schedule 13G beneficial ownership